Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Bisphenol A Controlled Exposure Study

ClinicalTrials.gov ID: NCT01573429

Public ClinicalTrials.gov record NCT01573429. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 9:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Bisphenol A (BPA) Pharmacokinetic (PK): Controlled Exposure Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Background: \- Bisphenol A (BPA) is a chemical that is used primarily to make plastics, resins, and thermal paper. Most people are exposed daily to low levels of BPA that leaches into food and water from plastic products, including water and baby bottles. However, not all of the risks of BPA are known. Researchers want to learn more about how BPA acts in the body, and how the body gets rid of BPA. Objectives: \- To study controlled exposure to BPA and its effects on the body. Eligibility: \- Healthy, non-obese volunteers between 25 and 45 years of age. Design: * Participants will have six visits over about 2 to 4 weeks for this study. * At the first visit, participants will be screened with a physical exam and blood and urine tests. They will complete a questionnaire about exposure to BPA-containing products. They will also receive a list of medications that should not be taken during the study period. * The second visit will last about 13 hours. Participants will fast for 8 hours before the visit. They will then have a single dose of d-BPA (a modified form of BPA that is easier to study in the body). Regular blood samples will be taken over the 13-hour visit. All urine will also be collected. Participants will receive breakfast and lunch during the visit. * Participants will have four follow-up visits. They will collect and store all of their urine between each follow-up visit. Blood samples will be collected at the follow-up visits....

Study identification

NCT ID
NCT01573429
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
38 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
25 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2012
Primary completion
Jun 15, 2020
Completion
Jun 15, 2020
Last update posted
Nov 17, 2021

2012 – 2020

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
NIEHS Clinical Research Unit (CRU) Research Triangle Park North Carolina

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Healthy Volunteers trials

Other public records listing Healthy Volunteers. Sorted by last update posted; newest first. Not a recommendation.

All Healthy Volunteers trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01573429, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2021 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01573429 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →